The miR-137 schizophrenia susceptibility variant rs1625579 does not predict variability in brain volume in a sample of schizophrenic patients and healthy individuals

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 165, Issue 6, 2014, Pages 467-471

  Rose, Emma J ^a,b,d   Morris, Derek W ^a   Fahey, Ciara ^a   Cannon, Dara ^c   Mcdonald, Colm ^c   Scanlon, Cathy ^c   Kelly, Sinead ^a,b   Gill, Michael ^a,b   Corvin, Aiden ^a,b   Donohoe, Gary ^a,b,c  

^a ST JAMES S HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Brain volume; MIR 137; Rs1625579; Schizophrenia; Voxel based morphometry

Indexed keywords

MICRORNA; MICRORNA 137; UNCLASSIFIED DRUG; MIRN137 MICRORNA, HUMAN;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN SIZE; CAUDATE NUCLEUS; CLINICAL PROTOCOL; COGNITION; CONTROLLED STUDY; DISEASE DURATION; DISEASE PREDISPOSITION; FEMALE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GLOBUS PALLIDUS; GRAY MATTER; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; NEUROANATOMY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; PREDICTION; PRIORITY JOURNAL; PUTAMEN; SCHIZOPHRENIA; SECONDARY ANALYSIS; SUBCORTEX; THALAMUS; VOLUMETRY; VOXEL BASED MORPHOMETRY; WHITE MATTER; BRAIN; BRAIN CORTEX; CASE CONTROL STUDY; DEMOGRAPHY; GENETIC PREDISPOSITION; GENETICS; ORGAN SIZE; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BRAIN; CASE-CONTROL STUDIES; CEREBRAL CORTEX; DEMOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICRORNAS; ORGAN SIZE; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 84906101705     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32249     Document Type: Article

References (26)

1. Ashburner J. 2007. A fast diffeomorphic image registration algorithm. Neuroimage 38(1):95-113.
2. Ashburner J, Friston KJ. 2000. Voxel-based morphometry - The methods. NeuroImage 11(6):805-821.
3. Cummings E, Donohoe G, Hargreaves A, Moore S, Fahey C, Dinan TG, McDonald C, O'Callaghan E, O'Neill FA, Waddington JL, Murphy KC, Morris DW, Gill M, Corvin A. 2013. Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the novel schizophrenia risk variant at MIR-137. Neurosci Lett 532:33-38.
4. Glahn DC, Thompson PM, Blangero J. 2007. Neuroimaging endophenotypes: strategies for finding genes influencing brain structure and function. Hum Brain Mapp 28(6):488-501.
5. Goldman AL, Pezawas L, Mattay VS, Fischl B, Verchinski BA, Chen Q, Weinberger DR, Meyer-Lindenberg A. 2009. Widespread reductions of cortical thickness in schizophrenia and spectrum disorders and evidence of heritability. Arch Gen Psychiatry 66(5):467-477.
6. Goldman AL, Pezawas L, Mattay VS, Fischl B, Verchinski BA, Zoltick B, Weinberger DR, Meyer-Lindenberg A. 2008. Heritability of brain morphology related to schizophrenia: a large-scale automated magnetic resonance imaging segmentation study. Biol Psychiatry 63(5):475-483.
7. Green MJ, Cairns MJ, Wu J, Dragovic M, Jablensky A, Tooney PA, Scott RJ, Carr VJ. 2012. Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia. Mol Psychiatry
8. Hayasaka S, Phan KL, Liberzon I, Worsley KJ, Nichols TE. 2004. Nonstationary cluster-size inference with random field and permutation methods. NeuroImage 22(2):676-687.
9. Honea RA, Meyer-Lindenberg A, Hobbs KB, Pezawas L, Mattay VS, Egan MF, Verchinski B, Passingham RE, Weinberger DR, Callicott JH. 2008. Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings. Biol Psychiatry 63(5):465-474.
10. Lett TA, Chakavarty MM, Felsky D, Brandl EJ, Tiwari AK, Gonçalves VF, Rajji TK, Daskalakis ZJ, Meltzer HY, Lieberman JA, Lerch JP, Mulsant BH, Kennedy JL, Voineskos AN. 2013. The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia. Mol Psychiatry 18(4):443-450.
11. McDonald C, Marshall N, Sham PC, Bullmore ET, Schulze K, Chapple B, Bramon E, Filbey F, Quraishi S, Walshe M, Murray RM. 2006. Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. Am J Psychiatry 163(3):478-487.
12. Moran ME, Hulshoff Pol H, Gogtay N. 2013. A family affair: brain abnormalities in siblings of patients with schizophrenia. Brain 136(11):3215-3226. doi: 10.1093/brain/awt116. Epub2013 May 22
13. Patenaude B, Smith SM, Kennedy DN, Jenkinson M. 2011. A Bayesian model of shape and appearance for subcortical brain segmentation. NeuroImage 56(3):907-922.
14. Peper JS, Brouwer RM, Boomsma DI, Kahn RS, Hulshoff Pol HE. 2007. Genetic influences on human brain structure: a review of brain imaging studies in twins. Hum Brain Mapp 28(6):464-473.
15. Perkins DO, Jeffries CD, Jarskog LF, Thomson JM, Woods K, Newman MA, Parker JS, Jin J, Hammond SM. 2007. microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome biology 8(2):R27.
16. Rose EJ, Donohoe G. 2012. Brain vs Behavior: An Effect Size Comparison of Neuroimaging and Cognitive Studies of Genetic Risk for Schizophrenia. Schizophr Bull
17. Rose EJ, Greene C, Kelly S, Morris DW, Robertson IH, Fahey C, Jacobson S, O'Doherty J, Newell FN, McGrath J, Bokde A, Garavan H, Frodl T, Gill M, Corvin AP, Donohoe G. 2012. The NOS1 variant rs6490121 is associated with variation in prefrontal function and grey matter density in healthy individuals. NeuroImage 60(1):614-622.
18. Schizophrenia Psychiatric Genome-Wide Association Study C. 2011. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 43(10):969-976.
19. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM. 2004. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 23(Suppl 1):S208-219.
20. Smrt RD, Szulwach KE, Pfeiffer RL, Li X, Guo W, Pathania M, Teng ZQ, Luo Y, Peng J, Bordey A, Jin P, Zhao X. 2010. MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1. Stem cells 28(6):1060-1070.
21. Thompson PM, Cannon TD, Narr KL, van Erp T, Poutanen VP, Huttunen M, Lonnqvist J, Standertskjold-Nordenstam CG, Kaprio J, Khaledy M, Dail R, Zoumalan CI, Toga AW. 2001. Genetic influences on brain structure. Nat Neurosci 4(12):1253-1258.
22. van Haren NE, Rijsdijk F, Schnack HG, Picchioni MM, Toulopoulou T, Weisbrod M, Sauer H, van Erp TG, Cannon TD, Huttunen MO, Boomsma DI, Hulshoff Pol HE, Murray RM, Kahn RS. 2012. The genetic and environmental determinants of the association between brain abnormalities and schizophrenia: the schizophrenia twins and relatives consortium. Biol Psychiat 71(10):915-921.
23. Whalley HC, Papmeyer M, Romaniuk L, Sprooten E, Johnstone EC, Hall J, Lawrie SM, Evans KL, Blumberg HP, Sussmann JE, McIntosh AM. 2012. Impact of a microRNA MIR137 susceptibility variant on brain function in people at high genetic risk of schizophrenia or bipolar disorder. Neuropsychopharmacology 37(12):2720-2729.
24. Willemsen MH, Valles A, Kirkels LA, Mastebroek M, Olde Loohuis N, Kos A, Wissink-Lindhout WM, de Brouwer AP, Nillesen WM, Pfundt R, Holder-Espinasse M, Vallee L, Andrieux J, Coppens-Hofman MC, Rensen H, Hamel BC, van Bokhoven H, Aschrafi A, Kleefstra T. 2011. Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability. J Med Genet 48(12):810-818.
25. Winkler AM, Kochunov P, Blangero J, Almasy L, Zilles K, Fox PT, Duggirala R, Glahn DC. 2010. Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies. NeuroImage 53(3):1135-1146.
26. Worsley KJ, Andermann M, Koulis T, MacDonald D, Evans AC. 1999. Detecting changes in nonisotropic images. Human Brain Mapping 8(2-3):98-101.